Results 161 to 170 of about 2,397 (207)

Estados Trombofílicos no doente com cancro. Incidência, profilaxia, tratamento e perpetivas futuras [PDF]

, 2012
Sara Raquel Lemos Rocha
core  

Estudio piloto comparativo heparina 5% versus Fibrilin [PDF]

Enfermería Nefrológica, 2013
Lamela Rivas, Lucía, Fernández Rivera, Constantino, Ornosa Agra, Carmen   +2 more
openaire   +3 more sources

El Uso de Heparinas de Bajo Peso Molecular como Profilaxis

Acta Médica Costarricense, 2012
Max Méndez-López, Andrés Romero-Pollini   +1 more
doaj   +2 more sources

[Clinical, diagnostic and therapeutic profile of patients with left intraventricular thrombus in three high-complexity centers during the period 2000-2022]. [PDF]

Arch Peru Cardiol Cir Cardiovasc
Lozano Pineda F, Cardona Buitrago C, Giraldo Ramírez S, Gándara Ricardo JA, Muñoz Ortiz E, Gallego Muñoz C, Valencia Duque JD, Mejía Guerra EA, Dallos Ferrerosa JN, Senior Sánchez JM.   +9 more
europepmc   +1 more source

Anticoagulants as panacea in COVID-19 infection. [PDF]

J Vasc Bras, 2020
Sobreira ML, Marques MA.
europepmc   +1 more source

[Heparina Vister].

Angiologia, 2003
openaire   +1 more source

Position Statement on the Use of Antiplatelet Agents and Anticoagulants in Patients Infected with the New Coronavirus (COVID-19) - 2020. [PDF]

Arq Bras Cardiol, 2020
Soeiro AM, Leal TCAT, Pereira MP, Lima EG, Figueiredo ACBDS, Petriz JLF, Precoma DB, Serrano CV.   +7 more
europepmc   +1 more source

Balancing the risks: continuous vs. interrupted anticoagulation during TAVI - what does the evidence say? [PDF]

Thromb J
Patel R, Kokori E, Olatunji G, Abraham IC, Akinboade A, Agyemang EA, Babalola A, Aderinto N.   +7 more
europepmc   +1 more source